These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The evolving landscape of neuroendocrine tumors. Bergsland EK Semin Oncol; 2013 Feb; 40(1):4-22. PubMed ID: 23391109 [TBL] [Abstract][Full Text] [Related]
23. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks. Shapiro B Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776 [TBL] [Abstract][Full Text] [Related]
24. [Neuroendocrine tumours of the gastrointestinal tract]. Plöckinger U; Wiedenmann B Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448 [TBL] [Abstract][Full Text] [Related]
26. [Somatostatin receptors. A new way to diagnosis and therapy of neuroendocrine tumors]. Wängberg B; Nilsson O; Wigander A; Johansson V; Forssell-Aronsson E; Andersson P; Fjälling M; Tisell LE; Ahlman H Lakartidningen; 1997 Mar; 94(10):829-30, 835-8. PubMed ID: 9102509 [TBL] [Abstract][Full Text] [Related]
27. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. Turaga KK; Kvols LK CA Cancer J Clin; 2011; 61(2):113-32. PubMed ID: 21388967 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis and treatment of carcinoid tumors. Oberg K Expert Rev Anticancer Ther; 2003 Dec; 3(6):863-77. PubMed ID: 14686708 [TBL] [Abstract][Full Text] [Related]
29. State of the art and future prospects in the management of neuroendocrine tumors. Oberg K Q J Nucl Med; 2000 Mar; 44(1):3-12. PubMed ID: 10932597 [TBL] [Abstract][Full Text] [Related]